nodes	percent_of_prediction	percent_of_DWPC	metapath
Melphalan—Alkylating Activity—Dacarbazine—peripheral nervous system neoplasm	0.802	1	CiPCiCtD
Melphalan—SLC22A3—Vincristine—peripheral nervous system neoplasm	0.0787	1	CbGbCtD
Melphalan—L-Tyrosine—TH—peripheral nervous system neoplasm	0.00162	0.604	CrCbGaD
Melphalan—L-Phenylalanine—TH—peripheral nervous system neoplasm	0.000941	0.35	CrCbGaD
Melphalan—SLC7A5—Isotretinoin—Tretinoin—peripheral nervous system neoplasm	0.000645	0.181	CbGdCrCtD
Melphalan—SLC7A5—Tretinoin—Isotretinoin—peripheral nervous system neoplasm	0.000645	0.181	CbGdCrCtD
Melphalan—SLC7A5—Alitretinoin—Isotretinoin—peripheral nervous system neoplasm	0.000645	0.181	CbGdCrCtD
Melphalan—SLC7A5—Alitretinoin—Tretinoin—peripheral nervous system neoplasm	0.000645	0.181	CbGdCrCtD
Melphalan—SLC7A5—Tretinoin—Alitretinoin—peripheral nervous system neoplasm	0.000489	0.137	CbGdCrCtD
Melphalan—SLC7A5—Isotretinoin—Alitretinoin—peripheral nervous system neoplasm	0.000489	0.137	CbGdCrCtD
Melphalan—Ibuprofen—ABCB1—peripheral nervous system neoplasm	0.000123	0.0458	CrCbGaD
Melphalan—Myalgia—Alitretinoin—peripheral nervous system neoplasm	0.0001	0.000884	CcSEcCtD
Melphalan—Unspecified disorder of skin and subcutaneous tissue—Alitretinoin—peripheral nervous system neoplasm	9.93e-05	0.000878	CcSEcCtD
Melphalan—Anorexia—Dactinomycin—peripheral nervous system neoplasm	9.85e-05	0.000871	CcSEcCtD
Melphalan—Mouth ulceration—Doxorubicin—peripheral nervous system neoplasm	9.83e-05	0.00087	CcSEcCtD
Melphalan—Neoplasm—Doxorubicin—peripheral nervous system neoplasm	9.83e-05	0.00087	CcSEcCtD
Melphalan—Bladder pain—Doxorubicin—peripheral nervous system neoplasm	9.83e-05	0.00087	CcSEcCtD
Melphalan—Convulsion—Vincristine—peripheral nervous system neoplasm	9.8e-05	0.000867	CcSEcCtD
Melphalan—Flushing—Etoposide—peripheral nervous system neoplasm	9.77e-05	0.000864	CcSEcCtD
Melphalan—Myalgia—Vincristine—peripheral nervous system neoplasm	9.63e-05	0.000852	CcSEcCtD
Melphalan—Anaphylactic shock—Alitretinoin—peripheral nervous system neoplasm	9.58e-05	0.000848	CcSEcCtD
Melphalan—Oedema—Alitretinoin—peripheral nervous system neoplasm	9.58e-05	0.000848	CcSEcCtD
Melphalan—Infection—Alitretinoin—peripheral nervous system neoplasm	9.52e-05	0.000842	CcSEcCtD
Melphalan—Immune system disorder—Etoposide—peripheral nervous system neoplasm	9.51e-05	0.000841	CcSEcCtD
Melphalan—Mediastinal disorder—Etoposide—peripheral nervous system neoplasm	9.49e-05	0.000839	CcSEcCtD
Melphalan—Musculoskeletal discomfort—Dactinomycin—peripheral nervous system neoplasm	9.42e-05	0.000833	CcSEcCtD
Melphalan—Hypersensitivity—Topotecan—peripheral nervous system neoplasm	9.39e-05	0.000831	CcSEcCtD
Melphalan—Thrombocytopenia—Alitretinoin—peripheral nervous system neoplasm	9.38e-05	0.00083	CcSEcCtD
Melphalan—Tachycardia—Alitretinoin—peripheral nervous system neoplasm	9.35e-05	0.000827	CcSEcCtD
Melphalan—Hypersensitivity—Tretinoin—peripheral nervous system neoplasm	9.32e-05	0.000824	CcSEcCtD
Melphalan—Hypersensitivity—Isotretinoin—peripheral nervous system neoplasm	9.32e-05	0.000824	CcSEcCtD
Melphalan—Skin disorder—Alitretinoin—peripheral nervous system neoplasm	9.31e-05	0.000823	CcSEcCtD
Melphalan—Alopecia—Etoposide—peripheral nervous system neoplasm	9.31e-05	0.000823	CcSEcCtD
Melphalan—Anaemia—Cisplatin—peripheral nervous system neoplasm	9.25e-05	0.000818	CcSEcCtD
Melphalan—Renal failure acute—Epirubicin—peripheral nervous system neoplasm	9.24e-05	0.000817	CcSEcCtD
Melphalan—Anaphylactic shock—Vincristine—peripheral nervous system neoplasm	9.24e-05	0.000817	CcSEcCtD
Melphalan—Oedema—Vincristine—peripheral nervous system neoplasm	9.24e-05	0.000817	CcSEcCtD
Melphalan—Infection—Vincristine—peripheral nervous system neoplasm	9.18e-05	0.000811	CcSEcCtD
Melphalan—Asthenia—Topotecan—peripheral nervous system neoplasm	9.15e-05	0.000809	CcSEcCtD
Melphalan—Anorexia—Alitretinoin—peripheral nervous system neoplasm	9.14e-05	0.000808	CcSEcCtD
Melphalan—Asthenia—Tretinoin—peripheral nervous system neoplasm	9.07e-05	0.000802	CcSEcCtD
Melphalan—Asthenia—Isotretinoin—peripheral nervous system neoplasm	9.07e-05	0.000802	CcSEcCtD
Melphalan—Thrombocytopenia—Vincristine—peripheral nervous system neoplasm	9.04e-05	0.0008	CcSEcCtD
Melphalan—Pruritus—Topotecan—peripheral nervous system neoplasm	9.02e-05	0.000798	CcSEcCtD
Melphalan—Decreased appetite—Dactinomycin—peripheral nervous system neoplasm	8.99e-05	0.000795	CcSEcCtD
Melphalan—Leukopenia—Cisplatin—peripheral nervous system neoplasm	8.96e-05	0.000792	CcSEcCtD
Melphalan—Hypotension—Alitretinoin—peripheral nervous system neoplasm	8.96e-05	0.000792	CcSEcCtD
Melphalan—Pruritus—Tretinoin—peripheral nervous system neoplasm	8.95e-05	0.000791	CcSEcCtD
Melphalan—Pruritus—Isotretinoin—peripheral nervous system neoplasm	8.95e-05	0.000791	CcSEcCtD
Melphalan—Fatigue—Dactinomycin—peripheral nervous system neoplasm	8.91e-05	0.000788	CcSEcCtD
Melphalan—Pain—Dactinomycin—peripheral nervous system neoplasm	8.84e-05	0.000782	CcSEcCtD
Melphalan—Anorexia—Vincristine—peripheral nervous system neoplasm	8.8e-05	0.000778	CcSEcCtD
Melphalan—Musculoskeletal discomfort—Alitretinoin—peripheral nervous system neoplasm	8.73e-05	0.000772	CcSEcCtD
Melphalan—Diarrhoea—Topotecan—peripheral nervous system neoplasm	8.72e-05	0.000771	CcSEcCtD
Melphalan—Convulsion—Cisplatin—peripheral nervous system neoplasm	8.67e-05	0.000767	CcSEcCtD
Melphalan—Diarrhoea—Tretinoin—peripheral nervous system neoplasm	8.65e-05	0.000765	CcSEcCtD
Melphalan—Diarrhoea—Isotretinoin—peripheral nervous system neoplasm	8.65e-05	0.000765	CcSEcCtD
Melphalan—Hypotension—Vincristine—peripheral nervous system neoplasm	8.63e-05	0.000763	CcSEcCtD
Melphalan—Paraesthesia—Alitretinoin—peripheral nervous system neoplasm	8.61e-05	0.000761	CcSEcCtD
Melphalan—Hyponatraemia—Epirubicin—peripheral nervous system neoplasm	8.57e-05	0.000758	CcSEcCtD
Melphalan—Renal failure acute—Doxorubicin—peripheral nervous system neoplasm	8.55e-05	0.000756	CcSEcCtD
Melphalan—Dyspnoea—Alitretinoin—peripheral nervous system neoplasm	8.54e-05	0.000756	CcSEcCtD
Melphalan—Myalgia—Cisplatin—peripheral nervous system neoplasm	8.52e-05	0.000753	CcSEcCtD
Melphalan—Anaemia—Etoposide—peripheral nervous system neoplasm	8.47e-05	0.000749	CcSEcCtD
Melphalan—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—peripheral nervous system neoplasm	8.46e-05	0.000748	CcSEcCtD
Melphalan—Dyspepsia—Alitretinoin—peripheral nervous system neoplasm	8.44e-05	0.000746	CcSEcCtD
Melphalan—Musculoskeletal discomfort—Vincristine—peripheral nervous system neoplasm	8.41e-05	0.000744	CcSEcCtD
Melphalan—Decreased appetite—Alitretinoin—peripheral nervous system neoplasm	8.33e-05	0.000737	CcSEcCtD
Melphalan—Paraesthesia—Vincristine—peripheral nervous system neoplasm	8.29e-05	0.000733	CcSEcCtD
Melphalan—Gastrointestinal disorder—Alitretinoin—peripheral nervous system neoplasm	8.27e-05	0.000732	CcSEcCtD
Melphalan—Fatigue—Alitretinoin—peripheral nervous system neoplasm	8.26e-05	0.000731	CcSEcCtD
Melphalan—Leukopenia—Etoposide—peripheral nervous system neoplasm	8.21e-05	0.000726	CcSEcCtD
Melphalan—Pain—Alitretinoin—peripheral nervous system neoplasm	8.2e-05	0.000725	CcSEcCtD
Melphalan—Anaphylactic shock—Cisplatin—peripheral nervous system neoplasm	8.17e-05	0.000722	CcSEcCtD
Melphalan—Oedema—Cisplatin—peripheral nervous system neoplasm	8.17e-05	0.000722	CcSEcCtD
Melphalan—Cardiac arrest—Epirubicin—peripheral nervous system neoplasm	8.11e-05	0.000717	CcSEcCtD
Melphalan—Infection—Cisplatin—peripheral nervous system neoplasm	8.11e-05	0.000717	CcSEcCtD
Melphalan—Vomiting—Topotecan—peripheral nervous system neoplasm	8.11e-05	0.000717	CcSEcCtD
Melphalan—Vomiting—Tretinoin—peripheral nervous system neoplasm	8.04e-05	0.000711	CcSEcCtD
Melphalan—Vomiting—Isotretinoin—peripheral nervous system neoplasm	8.04e-05	0.000711	CcSEcCtD
Melphalan—Rash—Topotecan—peripheral nervous system neoplasm	8.04e-05	0.000711	CcSEcCtD
Melphalan—Dermatitis—Topotecan—peripheral nervous system neoplasm	8.03e-05	0.00071	CcSEcCtD
Melphalan—Decreased appetite—Vincristine—peripheral nervous system neoplasm	8.03e-05	0.00071	CcSEcCtD
Melphalan—Cough—Etoposide—peripheral nervous system neoplasm	8e-05	0.000707	CcSEcCtD
Melphalan—Thrombocytopenia—Cisplatin—peripheral nervous system neoplasm	8e-05	0.000707	CcSEcCtD
Melphalan—Rash—Tretinoin—peripheral nervous system neoplasm	7.97e-05	0.000705	CcSEcCtD
Melphalan—Rash—Isotretinoin—peripheral nervous system neoplasm	7.97e-05	0.000705	CcSEcCtD
Melphalan—Gastrointestinal disorder—Vincristine—peripheral nervous system neoplasm	7.97e-05	0.000705	CcSEcCtD
Melphalan—Tachycardia—Cisplatin—peripheral nervous system neoplasm	7.97e-05	0.000705	CcSEcCtD
Melphalan—Dermatitis—Tretinoin—peripheral nervous system neoplasm	7.97e-05	0.000704	CcSEcCtD
Melphalan—Dermatitis—Isotretinoin—peripheral nervous system neoplasm	7.97e-05	0.000704	CcSEcCtD
Melphalan—Fatigue—Vincristine—peripheral nervous system neoplasm	7.96e-05	0.000704	CcSEcCtD
Melphalan—Convulsion—Etoposide—peripheral nervous system neoplasm	7.94e-05	0.000702	CcSEcCtD
Melphalan—Skin disorder—Cisplatin—peripheral nervous system neoplasm	7.93e-05	0.000701	CcSEcCtD
Melphalan—Hyponatraemia—Doxorubicin—peripheral nervous system neoplasm	7.93e-05	0.000701	CcSEcCtD
Melphalan—Pain—Vincristine—peripheral nervous system neoplasm	7.9e-05	0.000698	CcSEcCtD
Melphalan—Liver function test abnormal—Epirubicin—peripheral nervous system neoplasm	7.88e-05	0.000697	CcSEcCtD
Melphalan—Chest pain—Etoposide—peripheral nervous system neoplasm	7.8e-05	0.00069	CcSEcCtD
Melphalan—Anorexia—Cisplatin—peripheral nervous system neoplasm	7.78e-05	0.000688	CcSEcCtD
Melphalan—Unspecified disorder of skin and subcutaneous tissue—Etoposide—peripheral nervous system neoplasm	7.75e-05	0.000685	CcSEcCtD
Melphalan—Hypotension—Cisplatin—peripheral nervous system neoplasm	7.63e-05	0.000675	CcSEcCtD
Melphalan—Hypersensitivity—Dactinomycin—peripheral nervous system neoplasm	7.62e-05	0.000673	CcSEcCtD
Melphalan—Urticaria—Alitretinoin—peripheral nervous system neoplasm	7.61e-05	0.000673	CcSEcCtD
Melphalan—Nausea—Topotecan—peripheral nervous system neoplasm	7.57e-05	0.00067	CcSEcCtD
Melphalan—Nausea—Tretinoin—peripheral nervous system neoplasm	7.51e-05	0.000664	CcSEcCtD
Melphalan—Nausea—Isotretinoin—peripheral nervous system neoplasm	7.51e-05	0.000664	CcSEcCtD
Melphalan—Cardiac arrest—Doxorubicin—peripheral nervous system neoplasm	7.51e-05	0.000664	CcSEcCtD
Melphalan—Anaphylactic shock—Etoposide—peripheral nervous system neoplasm	7.48e-05	0.000662	CcSEcCtD
Melphalan—Musculoskeletal discomfort—Cisplatin—peripheral nervous system neoplasm	7.44e-05	0.000658	CcSEcCtD
Melphalan—Infection—Etoposide—peripheral nervous system neoplasm	7.43e-05	0.000657	CcSEcCtD
Melphalan—Asthenia—Dactinomycin—peripheral nervous system neoplasm	7.42e-05	0.000656	CcSEcCtD
Melphalan—Paraesthesia—Cisplatin—peripheral nervous system neoplasm	7.33e-05	0.000648	CcSEcCtD
Melphalan—Thrombocytopenia—Etoposide—peripheral nervous system neoplasm	7.33e-05	0.000648	CcSEcCtD
Melphalan—Tachycardia—Etoposide—peripheral nervous system neoplasm	7.3e-05	0.000646	CcSEcCtD
Melphalan—Liver function test abnormal—Doxorubicin—peripheral nervous system neoplasm	7.29e-05	0.000645	CcSEcCtD
Melphalan—Dyspnoea—Cisplatin—peripheral nervous system neoplasm	7.28e-05	0.000644	CcSEcCtD
Melphalan—Skin disorder—Etoposide—peripheral nervous system neoplasm	7.27e-05	0.000643	CcSEcCtD
Melphalan—Anorexia—Etoposide—peripheral nervous system neoplasm	7.13e-05	0.000631	CcSEcCtD
Melphalan—Decreased appetite—Cisplatin—peripheral nervous system neoplasm	7.1e-05	0.000628	CcSEcCtD
Melphalan—Diarrhoea—Dactinomycin—peripheral nervous system neoplasm	7.07e-05	0.000625	CcSEcCtD
Melphalan—Hypersensitivity—Alitretinoin—peripheral nervous system neoplasm	7.06e-05	0.000624	CcSEcCtD
Melphalan—Gastrointestinal disorder—Cisplatin—peripheral nervous system neoplasm	7.05e-05	0.000623	CcSEcCtD
Melphalan—Pancytopenia—Epirubicin—peripheral nervous system neoplasm	7e-05	0.000619	CcSEcCtD
Melphalan—Hypotension—Etoposide—peripheral nervous system neoplasm	6.99e-05	0.000618	CcSEcCtD
Melphalan—Pain—Cisplatin—peripheral nervous system neoplasm	6.98e-05	0.000618	CcSEcCtD
Melphalan—Neutropenia—Epirubicin—peripheral nervous system neoplasm	6.9e-05	0.00061	CcSEcCtD
Melphalan—Asthenia—Alitretinoin—peripheral nervous system neoplasm	6.88e-05	0.000608	CcSEcCtD
Melphalan—Hypersensitivity—Vincristine—peripheral nervous system neoplasm	6.8e-05	0.000602	CcSEcCtD
Melphalan—Pruritus—Alitretinoin—peripheral nervous system neoplasm	6.78e-05	0.0006	CcSEcCtD
Melphalan—Paraesthesia—Etoposide—peripheral nervous system neoplasm	6.72e-05	0.000594	CcSEcCtD
Melphalan—Dyspnoea—Etoposide—peripheral nervous system neoplasm	6.67e-05	0.00059	CcSEcCtD
Melphalan—Asthenia—Vincristine—peripheral nervous system neoplasm	6.63e-05	0.000586	CcSEcCtD
Melphalan—Vomiting—Dactinomycin—peripheral nervous system neoplasm	6.57e-05	0.000581	CcSEcCtD
Melphalan—Diarrhoea—Alitretinoin—peripheral nervous system neoplasm	6.56e-05	0.00058	CcSEcCtD
Melphalan—Rash—Dactinomycin—peripheral nervous system neoplasm	6.52e-05	0.000576	CcSEcCtD
Melphalan—Decreased appetite—Etoposide—peripheral nervous system neoplasm	6.5e-05	0.000575	CcSEcCtD
Melphalan—Pancytopenia—Doxorubicin—peripheral nervous system neoplasm	6.48e-05	0.000573	CcSEcCtD
Melphalan—Gastrointestinal disorder—Etoposide—peripheral nervous system neoplasm	6.46e-05	0.000571	CcSEcCtD
Melphalan—Fatigue—Etoposide—peripheral nervous system neoplasm	6.45e-05	0.00057	CcSEcCtD
Melphalan—Neuropathy peripheral—Epirubicin—peripheral nervous system neoplasm	6.45e-05	0.00057	CcSEcCtD
Melphalan—Stomatitis—Epirubicin—peripheral nervous system neoplasm	6.41e-05	0.000567	CcSEcCtD
Melphalan—Jaundice—Epirubicin—peripheral nervous system neoplasm	6.41e-05	0.000567	CcSEcCtD
Melphalan—Pain—Etoposide—peripheral nervous system neoplasm	6.4e-05	0.000566	CcSEcCtD
Melphalan—Neutropenia—Doxorubicin—peripheral nervous system neoplasm	6.38e-05	0.000564	CcSEcCtD
Melphalan—Diarrhoea—Vincristine—peripheral nervous system neoplasm	6.32e-05	0.000559	CcSEcCtD
Melphalan—Hepatobiliary disease—Epirubicin—peripheral nervous system neoplasm	6.22e-05	0.00055	CcSEcCtD
Melphalan—Nausea—Dactinomycin—peripheral nervous system neoplasm	6.14e-05	0.000543	CcSEcCtD
Melphalan—Vomiting—Alitretinoin—peripheral nervous system neoplasm	6.09e-05	0.000539	CcSEcCtD
Melphalan—Rash—Alitretinoin—peripheral nervous system neoplasm	6.04e-05	0.000534	CcSEcCtD
Melphalan—Dermatitis—Alitretinoin—peripheral nervous system neoplasm	6.04e-05	0.000534	CcSEcCtD
Melphalan—Hypersensitivity—Cisplatin—peripheral nervous system neoplasm	6.02e-05	0.000532	CcSEcCtD
Melphalan—Neuropathy peripheral—Doxorubicin—peripheral nervous system neoplasm	5.96e-05	0.000527	CcSEcCtD
Melphalan—Urticaria—Etoposide—peripheral nervous system neoplasm	5.94e-05	0.000526	CcSEcCtD
Melphalan—Haemoglobin—Epirubicin—peripheral nervous system neoplasm	5.93e-05	0.000525	CcSEcCtD
Melphalan—Stomatitis—Doxorubicin—peripheral nervous system neoplasm	5.93e-05	0.000524	CcSEcCtD
Melphalan—Jaundice—Doxorubicin—peripheral nervous system neoplasm	5.93e-05	0.000524	CcSEcCtD
Melphalan—Haemorrhage—Epirubicin—peripheral nervous system neoplasm	5.9e-05	0.000522	CcSEcCtD
Melphalan—Hepatitis—Epirubicin—peripheral nervous system neoplasm	5.9e-05	0.000522	CcSEcCtD
Melphalan—Vomiting—Vincristine—peripheral nervous system neoplasm	5.87e-05	0.000519	CcSEcCtD
Melphalan—Asthenia—Cisplatin—peripheral nervous system neoplasm	5.86e-05	0.000518	CcSEcCtD
Melphalan—Urinary tract disorder—Epirubicin—peripheral nervous system neoplasm	5.83e-05	0.000515	CcSEcCtD
Melphalan—Rash—Vincristine—peripheral nervous system neoplasm	5.82e-05	0.000515	CcSEcCtD
Melphalan—Dermatitis—Vincristine—peripheral nervous system neoplasm	5.82e-05	0.000514	CcSEcCtD
Melphalan—Connective tissue disorder—Epirubicin—peripheral nervous system neoplasm	5.8e-05	0.000513	CcSEcCtD
Melphalan—Urethral disorder—Epirubicin—peripheral nervous system neoplasm	5.79e-05	0.000512	CcSEcCtD
Melphalan—Hepatobiliary disease—Doxorubicin—peripheral nervous system neoplasm	5.75e-05	0.000509	CcSEcCtD
Melphalan—Nausea—Alitretinoin—peripheral nervous system neoplasm	5.69e-05	0.000503	CcSEcCtD
Melphalan—Diarrhoea—Cisplatin—peripheral nervous system neoplasm	5.59e-05	0.000494	CcSEcCtD
Melphalan—Hypersensitivity—Etoposide—peripheral nervous system neoplasm	5.51e-05	0.000487	CcSEcCtD
Melphalan—Haemoglobin—Doxorubicin—peripheral nervous system neoplasm	5.49e-05	0.000485	CcSEcCtD
Melphalan—Nausea—Vincristine—peripheral nervous system neoplasm	5.49e-05	0.000485	CcSEcCtD
Melphalan—Flushing—Epirubicin—peripheral nervous system neoplasm	5.48e-05	0.000484	CcSEcCtD
Melphalan—Hepatitis—Doxorubicin—peripheral nervous system neoplasm	5.46e-05	0.000483	CcSEcCtD
Melphalan—Haemorrhage—Doxorubicin—peripheral nervous system neoplasm	5.46e-05	0.000483	CcSEcCtD
Melphalan—Urinary tract disorder—Doxorubicin—peripheral nervous system neoplasm	5.39e-05	0.000477	CcSEcCtD
Melphalan—Asthenia—Etoposide—peripheral nervous system neoplasm	5.37e-05	0.000475	CcSEcCtD
Melphalan—Connective tissue disorder—Doxorubicin—peripheral nervous system neoplasm	5.37e-05	0.000475	CcSEcCtD
Melphalan—Urethral disorder—Doxorubicin—peripheral nervous system neoplasm	5.35e-05	0.000473	CcSEcCtD
Melphalan—Immune system disorder—Epirubicin—peripheral nervous system neoplasm	5.33e-05	0.000471	CcSEcCtD
Melphalan—Mediastinal disorder—Epirubicin—peripheral nervous system neoplasm	5.32e-05	0.00047	CcSEcCtD
Melphalan—Pruritus—Etoposide—peripheral nervous system neoplasm	5.29e-05	0.000468	CcSEcCtD
Melphalan—Arrhythmia—Epirubicin—peripheral nervous system neoplasm	5.27e-05	0.000466	CcSEcCtD
Melphalan—Alopecia—Epirubicin—peripheral nervous system neoplasm	5.22e-05	0.000461	CcSEcCtD
Melphalan—Vomiting—Cisplatin—peripheral nervous system neoplasm	5.19e-05	0.000459	CcSEcCtD
Melphalan—Rash—Cisplatin—peripheral nervous system neoplasm	5.15e-05	0.000455	CcSEcCtD
Melphalan—Dermatitis—Cisplatin—peripheral nervous system neoplasm	5.14e-05	0.000455	CcSEcCtD
Melphalan—Diarrhoea—Etoposide—peripheral nervous system neoplasm	5.12e-05	0.000453	CcSEcCtD
Melphalan—Flushing—Doxorubicin—peripheral nervous system neoplasm	5.07e-05	0.000448	CcSEcCtD
Melphalan—Immune system disorder—Doxorubicin—peripheral nervous system neoplasm	4.93e-05	0.000436	CcSEcCtD
Melphalan—Mediastinal disorder—Doxorubicin—peripheral nervous system neoplasm	4.92e-05	0.000435	CcSEcCtD
Melphalan—Arrhythmia—Doxorubicin—peripheral nervous system neoplasm	4.88e-05	0.000431	CcSEcCtD
Melphalan—Nausea—Cisplatin—peripheral nervous system neoplasm	4.85e-05	0.000429	CcSEcCtD
Melphalan—Alopecia—Doxorubicin—peripheral nervous system neoplasm	4.83e-05	0.000427	CcSEcCtD
Melphalan—Vomiting—Etoposide—peripheral nervous system neoplasm	4.76e-05	0.000421	CcSEcCtD
Melphalan—Anaemia—Epirubicin—peripheral nervous system neoplasm	4.75e-05	0.00042	CcSEcCtD
Melphalan—Rash—Etoposide—peripheral nervous system neoplasm	4.72e-05	0.000417	CcSEcCtD
Melphalan—Dermatitis—Etoposide—peripheral nervous system neoplasm	4.71e-05	0.000417	CcSEcCtD
Melphalan—Leukopenia—Epirubicin—peripheral nervous system neoplasm	4.6e-05	0.000407	CcSEcCtD
Melphalan—Cough—Epirubicin—peripheral nervous system neoplasm	4.48e-05	0.000397	CcSEcCtD
Melphalan—Convulsion—Epirubicin—peripheral nervous system neoplasm	4.45e-05	0.000394	CcSEcCtD
Melphalan—Nausea—Etoposide—peripheral nervous system neoplasm	4.44e-05	0.000393	CcSEcCtD
Melphalan—Anaemia—Doxorubicin—peripheral nervous system neoplasm	4.39e-05	0.000389	CcSEcCtD
Melphalan—Chest pain—Epirubicin—peripheral nervous system neoplasm	4.37e-05	0.000387	CcSEcCtD
Melphalan—Myalgia—Epirubicin—peripheral nervous system neoplasm	4.37e-05	0.000387	CcSEcCtD
Melphalan—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—peripheral nervous system neoplasm	4.34e-05	0.000384	CcSEcCtD
Melphalan—Leukopenia—Doxorubicin—peripheral nervous system neoplasm	4.26e-05	0.000376	CcSEcCtD
Melphalan—Oedema—Epirubicin—peripheral nervous system neoplasm	4.19e-05	0.000371	CcSEcCtD
Melphalan—Anaphylactic shock—Epirubicin—peripheral nervous system neoplasm	4.19e-05	0.000371	CcSEcCtD
Melphalan—Infection—Epirubicin—peripheral nervous system neoplasm	4.17e-05	0.000368	CcSEcCtD
Melphalan—Cough—Doxorubicin—peripheral nervous system neoplasm	4.15e-05	0.000367	CcSEcCtD
Melphalan—Convulsion—Doxorubicin—peripheral nervous system neoplasm	4.12e-05	0.000364	CcSEcCtD
Melphalan—Thrombocytopenia—Epirubicin—peripheral nervous system neoplasm	4.11e-05	0.000363	CcSEcCtD
Melphalan—Tachycardia—Epirubicin—peripheral nervous system neoplasm	4.09e-05	0.000362	CcSEcCtD
Melphalan—Skin disorder—Epirubicin—peripheral nervous system neoplasm	4.07e-05	0.00036	CcSEcCtD
Melphalan—Chest pain—Doxorubicin—peripheral nervous system neoplasm	4.05e-05	0.000358	CcSEcCtD
Melphalan—Myalgia—Doxorubicin—peripheral nervous system neoplasm	4.05e-05	0.000358	CcSEcCtD
Melphalan—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—peripheral nervous system neoplasm	4.02e-05	0.000355	CcSEcCtD
Melphalan—Anorexia—Epirubicin—peripheral nervous system neoplasm	4e-05	0.000353	CcSEcCtD
Melphalan—Hypotension—Epirubicin—peripheral nervous system neoplasm	3.92e-05	0.000347	CcSEcCtD
Melphalan—Anaphylactic shock—Doxorubicin—peripheral nervous system neoplasm	3.88e-05	0.000343	CcSEcCtD
Melphalan—Oedema—Doxorubicin—peripheral nervous system neoplasm	3.88e-05	0.000343	CcSEcCtD
Melphalan—Infection—Doxorubicin—peripheral nervous system neoplasm	3.86e-05	0.000341	CcSEcCtD
Melphalan—Musculoskeletal discomfort—Epirubicin—peripheral nervous system neoplasm	3.82e-05	0.000338	CcSEcCtD
Melphalan—Thrombocytopenia—Doxorubicin—peripheral nervous system neoplasm	3.8e-05	0.000336	CcSEcCtD
Melphalan—Tachycardia—Doxorubicin—peripheral nervous system neoplasm	3.79e-05	0.000335	CcSEcCtD
Melphalan—Skin disorder—Doxorubicin—peripheral nervous system neoplasm	3.77e-05	0.000333	CcSEcCtD
Melphalan—Paraesthesia—Epirubicin—peripheral nervous system neoplasm	3.77e-05	0.000333	CcSEcCtD
Melphalan—Dyspnoea—Epirubicin—peripheral nervous system neoplasm	3.74e-05	0.000331	CcSEcCtD
Melphalan—Anorexia—Doxorubicin—peripheral nervous system neoplasm	3.7e-05	0.000327	CcSEcCtD
Melphalan—Dyspepsia—Epirubicin—peripheral nervous system neoplasm	3.69e-05	0.000326	CcSEcCtD
Melphalan—Decreased appetite—Epirubicin—peripheral nervous system neoplasm	3.65e-05	0.000322	CcSEcCtD
Melphalan—Hypotension—Doxorubicin—peripheral nervous system neoplasm	3.63e-05	0.000321	CcSEcCtD
Melphalan—Gastrointestinal disorder—Epirubicin—peripheral nervous system neoplasm	3.62e-05	0.00032	CcSEcCtD
Melphalan—Fatigue—Epirubicin—peripheral nervous system neoplasm	3.62e-05	0.00032	CcSEcCtD
Melphalan—Pain—Epirubicin—peripheral nervous system neoplasm	3.59e-05	0.000317	CcSEcCtD
Melphalan—Musculoskeletal discomfort—Doxorubicin—peripheral nervous system neoplasm	3.54e-05	0.000313	CcSEcCtD
Melphalan—Paraesthesia—Doxorubicin—peripheral nervous system neoplasm	3.48e-05	0.000308	CcSEcCtD
Melphalan—Dyspnoea—Doxorubicin—peripheral nervous system neoplasm	3.46e-05	0.000306	CcSEcCtD
Melphalan—Dyspepsia—Doxorubicin—peripheral nervous system neoplasm	3.42e-05	0.000302	CcSEcCtD
Melphalan—Decreased appetite—Doxorubicin—peripheral nervous system neoplasm	3.37e-05	0.000298	CcSEcCtD
Melphalan—Gastrointestinal disorder—Doxorubicin—peripheral nervous system neoplasm	3.35e-05	0.000296	CcSEcCtD
Melphalan—Fatigue—Doxorubicin—peripheral nervous system neoplasm	3.35e-05	0.000296	CcSEcCtD
Melphalan—Urticaria—Epirubicin—peripheral nervous system neoplasm	3.33e-05	0.000295	CcSEcCtD
Melphalan—Pain—Doxorubicin—peripheral nervous system neoplasm	3.32e-05	0.000293	CcSEcCtD
Melphalan—Hypersensitivity—Epirubicin—peripheral nervous system neoplasm	3.09e-05	0.000273	CcSEcCtD
Melphalan—Urticaria—Doxorubicin—peripheral nervous system neoplasm	3.08e-05	0.000273	CcSEcCtD
Melphalan—Asthenia—Epirubicin—peripheral nervous system neoplasm	3.01e-05	0.000266	CcSEcCtD
Melphalan—Pruritus—Epirubicin—peripheral nervous system neoplasm	2.97e-05	0.000262	CcSEcCtD
Melphalan—Diarrhoea—Epirubicin—peripheral nervous system neoplasm	2.87e-05	0.000254	CcSEcCtD
Melphalan—Hypersensitivity—Doxorubicin—peripheral nervous system neoplasm	2.86e-05	0.000253	CcSEcCtD
Melphalan—Asthenia—Doxorubicin—peripheral nervous system neoplasm	2.78e-05	0.000246	CcSEcCtD
Melphalan—Pruritus—Doxorubicin—peripheral nervous system neoplasm	2.75e-05	0.000243	CcSEcCtD
Melphalan—Vomiting—Epirubicin—peripheral nervous system neoplasm	2.67e-05	0.000236	CcSEcCtD
Melphalan—Diarrhoea—Doxorubicin—peripheral nervous system neoplasm	2.65e-05	0.000235	CcSEcCtD
Melphalan—Rash—Epirubicin—peripheral nervous system neoplasm	2.64e-05	0.000234	CcSEcCtD
Melphalan—Dermatitis—Epirubicin—peripheral nervous system neoplasm	2.64e-05	0.000234	CcSEcCtD
Melphalan—Nausea—Epirubicin—peripheral nervous system neoplasm	2.49e-05	0.00022	CcSEcCtD
Melphalan—Vomiting—Doxorubicin—peripheral nervous system neoplasm	2.47e-05	0.000218	CcSEcCtD
Melphalan—Rash—Doxorubicin—peripheral nervous system neoplasm	2.45e-05	0.000216	CcSEcCtD
Melphalan—Dermatitis—Doxorubicin—peripheral nervous system neoplasm	2.44e-05	0.000216	CcSEcCtD
Melphalan—Nausea—Doxorubicin—peripheral nervous system neoplasm	2.3e-05	0.000204	CcSEcCtD
